Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|December 1, 1996
Supplements and Featured Publications
- Creating an Optimal Strategy for Lipid Management
- Volume 2
- Issue 11 Suppl
Recent Clinical Trials and Aggressive Management of Dyslipidemic Patients
Author(s)Donald B. Hunninghake, MD
Advertisement
Articles in this issue
almost 30 years ago
Dialogue: Implementation of Guidelines in a Managed Care Settingalmost 30 years ago
Dialogue: The Lipid-Lowering Formularyalmost 30 years ago
Case Study Balmost 30 years ago
Case Study Calmost 30 years ago
Case Study Dalmost 30 years ago
Goals and Objectivesalmost 30 years ago
Introduction: Creating an Optimal Strategy for Lipid Managementalmost 30 years ago
Epidemiologic Studies of Diet and Drug Therapy to Reach Target LDL-C Levelsalmost 30 years ago
Implementation of Guidelines in a Managed Care Settingalmost 30 years ago
The Lipid-Lowering FormularyAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Multiagonists Outpace Older GLP-1 Drugs for Weight Loss
2
The Next Frontier in Hepatitis B Functional and Virologic Cure
3
Cardiac Risks of COVID-19 Vaccine vs Infection: Eman Toraih, MD, PhD
4
Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM
5